Tokyo Tape
Sign in
← Fukuda Denshi

Quarterly report · Q2

6960.TEDINET S100S7MX
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥66.5bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥134.6bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥62.6bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥14.0bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥11.1bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥14.1bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥25.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥11.7bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥14.3bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥11.8bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥9.8bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥8.1bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥9.8bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥8.1bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥210.8bnat 2023-09-30Cons.Assets
Total assets¥206.9bnat 2023-03-31Cons.Assets
Total assets¥196.9bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥39.3bnat 2023-09-30Cons.Liabilities
Total liabilities¥43.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥171.5bnat 2023-09-30Cons.Net assets
Net assets / equity¥163.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥155.1bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥70.5bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥68.0bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥67.5bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥63.4bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥61.0bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥10.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥23.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥11.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥4.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥14.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥6.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥324.322023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥208.782023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥571.252022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥268.432022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥174.152022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio81.3%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio78.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥20.5bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥20.5bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥4.1bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥29.3bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥29.3bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.7bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥3.8bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥3.8bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥737m
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2023-04-01 → 2023-09-30¥13.0bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2023-04-01 → 2023-09-30¥13.0bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2023-04-01 → 2023-09-30¥2.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥66.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥66.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥14.0bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥17.1bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥17.1bn
jpcrp040300-q2r_E02304-000Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.1bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥26.9bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥26.9bn
jpcrp040300-q2r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥6.0bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥5.2bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥5.2bn
jpcrp040300-q2r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥881m
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥13.4bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥13.4bn
jpcrp040300-q2r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥62.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥62.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥11.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 520
ItemContextValueUnit
Foreign exchange losses noePrior1YTDDuration－JPY
Foreign exchange losses noeCurrentYTDDuration68000000JPY
Other noePrior1YTDDuration4000000JPY
Other noeCurrentYTDDuration14000000JPY
Non operating expensesPrior1YTDDuration22000000JPY
Non operating expensesCurrentYTDDuration100000000JPY
Ordinary incomePrior1YTDDuration11662000000JPY
Ordinary incomeCurrentYTDDuration14099000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration7000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration4000000JPY
Surrender value of insurance eiPrior1YTDDuration163000000JPY
Surrender value of insurance eiCurrentYTDDuration194000000JPY
Gain on extinguishment of tie in shares eiPrior1YTDDuration67000000JPY
Gain on extinguishment of tie in shares eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration239000000JPY
Extraordinary incomeCurrentYTDDuration199000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration0JPY
Loss on sales of noncurrent assets elCurrentYTDDuration5000000JPY
Impairment loss elPrior1YTDDuration58000000JPY
Impairment loss elCurrentYTDDuration4000000JPY
Loss on valuation of investment securities elPrior1YTDDuration48000000JPY
Loss on valuation of investment securities elCurrentYTDDuration－JPY
Office transfer expenses elPrior1YTDDuration－JPY
Office transfer expenses elCurrentYTDDuration8000000JPY
Other elPrior1YTDDuration0JPY
Other elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration108000000JPY
Extraordinary lossCurrentYTDDuration18000000JPY
Income before income taxesPrior1YTDDuration11792000000JPY
Income before income taxesCurrentYTDDuration14280000000JPY
Income taxes currentPrior1YTDDuration3576000000JPY
Income taxes currentCurrentYTDDuration4286000000JPY
Income taxes deferredPrior1YTDDuration97000000JPY
Income taxes deferredCurrentYTDDuration183000000JPY
Income taxesPrior1YTDDuration3673000000JPY
Income taxesCurrentYTDDuration4469000000JPY
Profit lossPrior1YTDDuration8119000000JPY
Profit lossCurrentYTDDuration9810000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration8119000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration9810000000JPY
Profit lossPrior1YTDDuration8119000000JPY
Profit lossCurrentYTDDuration9810000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-141000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration1372000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration403000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration310000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration21000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-19000000JPY
Other comprehensive incomePrior1YTDDuration282000000JPY
Other comprehensive incomeCurrentYTDDuration1664000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass